September 22nd, 2021
•Presented is a protocol for the expansion of Gamma-Delta (γδ) T cell drug product. Lymphocytes are isolated by elutriation and γδ-enriched with zoledronic acid and interleukin-2. Alpha-beta T cells are depleted using a clinical-grade magnetic separation device. The γδ cells are co-cultured with K562-derived, artificial antigen-presenting cells and expanded.
Tags
Related Videos
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Real-Time Detection and Capture of Invasive Cell Subpopulations from Co-Cultures
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved